Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early preventive caffeine citrate for brain protection in premature infants
ChiCTR2200057419Phase 4Not yet recruiting
- Sponsor
- Children's Hospital of Fudan University
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of caffeine in apnea of prematurity (AOP) (2 arms), sponsored by Children's Hospital of Fudan University. Primary endpoint: Incidence of composite endpoint events. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on ChiCTR2200057419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057419.